US Stocks
US Options
Emerging Asia
GBP Cash Savings
Charts & Tools
Paper Trading
Extended Hours
Wall Street Journal
TradingViewA
ARCT
Arcturus Therape
7.59
0.32+4.40%Closed18:58 01/22 EST
OPEN/PREV CLOSE7.36/7.27
TODAY RANGE7.32-7.89
VOL642.80K
MARKET CAP215.66M
52 WEEK RANGE5.85-24.17
AVG VOL (3M)887.59K
% TURNOVER2.26%
TURNOVER0
P/E (TTM)-3.0855
% RANGE7.84%
EPS(TTM)-2.4599
P/E(FORWARD)-3.3884
P/B0.9205
BVPS8.25
DIVIDEND--
P/S1.345
BETA--
DIV YIELD0.00%
FREE FLOAT MKT CAP199.43M
SHARES OUTSTANDING28.41M
NEXT EARNINGS03/04-03/09
FREE FLOAT26.28M
LOT SIZE1
EX-DATE11/16/2017
News
Press Releases
Financial Reports
Profile
Dow Jones·01/06 18:48
Arcturus Therapeutics Is Maintained at Neutral by Citigroup
Dow Jones·01/06 18:48
Arcturus Therapeutics Price Target Cut to $7.00/Share From $9.00 by Citigroup
Benzinga·01/06 18:38
Citigroup Maintains Neutral on Arcturus Therapeutics, Lowers Price Target to $7
TipRanks·01/06 11:21
Arcturus Therapeutics price target lowered to $7 from $9 at Citi
Reuters·01/06 07:53
U.S. RESEARCH ROUNDUP-Brunswick, Parker-Hannifin, XPLR Infrastructure
TipRanks·12/30/2025 21:05
Arcturus Therapeutics files $500M mixed securities shelf
Benzinga·12/30/2025 21:04
Arcturus Therapeutics Holdings Files For Mixed Shelf Of Up To $500M
Reuters·12/30/2025 21:01
ARCTURUS THERAPEUTICS HOLDINGS INC FILES FOR MIXED SHELF OF UP TO $500 MLN - SEC FILING
Reuters·12/19/2025 22:20
Arcturus Therapeutics Files Initial Beneficial Ownership Statement for Controller Joseph Roberts
TipRanks·12/15/2025 14:00
Arcturus Therapeutics Announces CFO Departure and Replacement
Reuters·12/15/2025 13:32
ARCTURUS THERAPEUTICS HOLDINGS INC - CFO ANDY SASSINE TO LEAVE COMPANY - SEC FILING
Same Industry
Name/Symbol
Change%
Price